Endpoints News 10. Feb. 2026 AstraZeneca’s obesity pill hits in Phase 2, key cancer trials pushed back
Endpoints News 10. Feb. 2026 Hengrui, Kailera push obesity pill ahead on promising mid-stage China data
Endpoints News 9. Feb. 2026 #ACTRIMS26: Roche’s MS drug fenebrutinib beats Ocrevus, cutting risk of disability progression by 12%
Endpoints News 9. Feb. 2026 Novo Nordisk sues Hims over Wegovy patent infringement, considers seeking 'hundreds of millions' in damages
Endpoints News 7. Feb. 2026 #ACTRIMS26: Sanofi unpacks data from a failed Phase 3 tolebrutinib trial in PPMS
Endpoints News 7. Feb. 2026 The Hims vs. Novo showdown; Pfizer’s monthly GLP-1 data; Q4 earnings roundup; and more